Pathogenesis of Secretory Otitis Media

Open access

Abstract

Secretory otitis media (SOM) is a common and frequently occurring disease featured by middle ear cavity exudant, ear nausea, and hearing loss. Morbidity of children is higher than that of adults. The pathogenesis and etiology of SOM are clear so far. Previous reports concluded that the mechanical obstruction and dysfunction of the eustachian tube are among the important causes of infection. The mechanism of infection and immune response in the pathogenesis of SOM is currently becoming a research hot spot, providing a reference for further study.

References

  • 1 Cunsolo E, Marchioni D, Leo G, et al. Functional anatomy of the eustachian tube. Int J Immunopathol Pharmacol, 2010, 23(1 Suppl): 4-7.

  • 2 Ryding M, White P, Kalm O. Eustachian tube function and tympanic membrane findings after chronic secretory otitis media. Int J Pediatr Otorhinolaryngol, 2004, 68(2): 197-204.

  • 3 Ma Z, Chen X, Li M, et al. Progress in the treatment of secretory otitis media with surfactant. Ting Li Xue Ji Ji Bing Yan Wu Ji Bing Za Zhi, 2003, 11: 67.

  • 4 Yuan Y, LI G, Zhou W, et al. Study on the relationship between ostium pharyngeum tubae auditivae and its surrounding morphological changes and secretory otitis media. Lin Chuang Er Bi Hou Tou Jing Wai Ke Za Zhi, 2007, 21: 1024.

  • 5 Kanai R, Kaneko K. Negative middle ear pressure and otitis media with effusion after surgery under general anesthesia. Acta Otolaryngol, 2012, 132(10): 1049-1053.

  • 6 Lin J, Mu Z, Yu G, et al. Diagnosis and treatment of nasal secretory otitis media. Lin Chuang Er Bi Hou Tou Jing Wai Ke Za Zhi, 2011, 25: 301.

  • 7 Yasan H, Dogru H, Tuz M, et al. Otilis medi a with effusion and histopatholog ic proper t ies of adenoid t issue. Int J Pediat r Otorhinolaryngol, 2003, 67(11): 1179-1183.

  • 8 Becker S, Koch T, Philipp A. Allergic origin of recurrent middle ear exudant and adenoids in young children. HNO, 1991, 39(5): 182-184.

  • 9 Takahashi H, Fujita A, Lee SH, et al. Experimental conditions for the development of persistent otitis media with effusion. Eur Arch Otorhinolaryngol,1990, 247(2): 89-92.

  • 10 Zhang Z, Liu H. Pathogenesis of secretory otitis media. Yi Xue Zong Shu, 2004, 10: 751.

  • 11 Brockson ME, Novotny LA, Jurcisek JA, et al. Respiratory syncytial virus promotes moraxella catarrhalis-induced ascending experimental otitis media. PLoS One, 2012, 7(6): e40088.

  • 12 Daniel M, Imtiaz-Umer S, Fergie N, et al. Bacterial involvement in otitis media with effusion. Int J Pediatr Otorhinolaryngol, 2012, 76(10): 1416-1422.

  • 13 Grossman J. One airway, one disease. Chest, 1997, 111(2 Suppl): 11S-16S.

  • 14 Gu Z. Respiratory tract inflammatory response. Zhonghua Er Bi Yan Hou Ke Za Zhi, 2001, 36: 80.

  • 15 Suenaga S, Kodama S, Ueyama S, et al. Mucosal immunity of the middle ear: analysis at the single cell level. Laryngoscope, 2001, 111(2): 290-296.

  • 16 Alles R, Parikh A, Hawk L, et al. The prevalence of atopic disorders in children with chronic otitis media with effusion. Pediatr Allergy Immunol, 2001, 12(2): 102-106.

  • 17 Smirnova MG, Birchall JP, Pearson JP. Evidence of T-helper cell 2 cytokine regulation of chronic otitis media with effusion. Acta Otolaryngol, 2005, 125(10): 1043-1050.

  • 18 Nguyen LH, Manoukian JJ, Sobol SE, et al. Similar allergic inflammation in the middle ear and the upper airway: evidence linking otitis media with effusion to the united airways concept. J Allergy Clin Immunol, 2004, 114(5): 1110-1115.

  • 19 Ishizaki K,Yamada A,Yoh K, et al. Th1 and type 1 cytotoxic T cells dominate responses in T-bet overexpression transgenic mice that develop contact dermatitis. J Immunol, 2007, 178(1): 605-612.

  • 20 Leigh R, Ellis R, Wattie JN, et al. Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med, 2004, 169(7): 860-867.

  • 21 Zhao S, Liu H, Han D, et al. Expression of middle ear nuclear factor κB in exudative otitis media of rats induced by allergen. Lin Chuang Er Bi Hou Tou Jing Wai Ke Za Zhi, 2008, 22: 751.

  • 22 Kariya S, Okano M, Hattori H, et al. TH1/TH2 and regulatory cytokines in adults with otitis media with effusion. Otol Neurotol, 2006, 27(8): 1089-1093.

  • 23 Skotnicka B, Stasial-Barmuta A, Hassmann-Poznanske E, et a l. Lymphocyte subpopulations in middle ear exudant: f low cytometry analysis. Otol Neurotol, 2005, 26(4): 567-571.

  • 24 Cooter MS, Eisma RJ, Burleson JA, et al. Transforming growth factorbeta expression in otitis media with effusion. Laryngoscope, 1998, 108(7): 1066-1070.

  • 25 Li J, Zhao S, Liu H, et al. Clinical significance of detection of TGF-β1 in middle ear exudant of secretory otitis media. Ting Li Xue Ji Ji Bing Yan Wu Ji Bing Za Zhi, 2008, 16: 383.

  • 26 Daniele N, Scerpa MC, Landi F, et al. T (reg) cells: collection, processing, storage, and clinical use. Pathol Res Pract, 2011, 207(4): 209-215.

  • 27 Joetham A, Takada K, Taube C, et al. Naturally occurring lung CD4+, CD25+ T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J Immunol, 2007, 178(3): 1433-1442.

  • 28 Mall M, Grubb BR, Harkema JR, et al. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med, 2004, 10(5): 487-493.

  • 29 Verkman AS, Mitra AK. Structure and function of aquaporin water channels. Am J Physiol Renal Fluid Electrolyte Physiol, 2000, 278: F13.

  • 30 Lim DJ, Chun YM, Lee SK, et al. Cell biology of tubotympanum in relation to pathogenesis of otitis media-a review. Vaccine, 2001, 19 Suppl 1: S17-S25.

  • 31 Zhang Q, Liu C, Wang J, et al. Expression pattern of aquaporin 4 and 5 in the middle ear of guinea pigs with secretory otitis media. Acta Oto-Laryngologica, 2010, 130(1): 68-74.

  • 32 Frede S, Berchner-Pfannschmidt U, Fandrey J. Reg ulat ion of hypoxiainducible factors during inf lammation. Meth Enzymol, 2007, 435: 405-419.

  • 33 Dehne N, Brune B. HIF-1 in the inflammatory microenvironment. Exp Cell Res, 2009, 315(11): 1791-1797.

  • 34 Doedens A, Johnson RS. Transgenic mode l s to u nde r s t a nd hypoxiainducible factor function. Meth Enzymol, 2007, 435: 87-105.

  • 35 Rius J, Guma M, Schachtrup C, et al. NF-kB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1a. Nature, 2008, 453(7196): 807-811.

  • 36 Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inf lammation. J Physiol, 2008, 586(17): 4055-4059.

  • 37 Oliver KM, Taylor CT, Cummins EP. Hypoxia regulation of NFkappaB signaling during inf lammation: the role of hydroxylases. Arthritis Res Ther, 2009, 11(1): 215.

  • 38 Zinkernagel A, Johnson R, Nizet V. Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med (Berl), 2007, 85(12): 1339-1346.

  • 39 Huang Q, Cai X, Zhang Z, et al. Expression of hypoxia-inducible factor in otic mucosa of rats with secretory otitis media. Ting Li Xue Ji Ji Bing Yan Wu Ji Bing Za Zhi, 2010, 18: 63.

  • 40 Cheeseman MT, Tyrer HE, Williams D, et al. HIF-VEGF pathways are critical for chronic otitis media in junbo and jeff mouse mutants. PLoS Genet, 2011, 7: e1002336.

  • 41 Kim SH, Park DC, Byun JY, et al. The relationship between overweight and otitis media with effusion in children. Int J Obes (Lond), 2011, 35(2): 279-282.

Journal Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 19 19 18
PDF Downloads 3 3 3